𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in adult granulosa cell tumor of the ovary

✍ Scribed by Brigitte E. Miller; Beth A. Barron; Jim Y. Wan; James E. Delmore; Elvio G. Silva; David M. Gershenson


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
71 KB
Volume
79
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

The clinical course of adult granulosa cell tumor of the ovary is characterized by indolent growth tending toward late recurrence. a variety of clinical and pathologic parameters have previously been evaluated for prognostication with inconclusive results.

Methods:

The clinical records and tumor sections of 70 patients with adult granulosa cell tumors of the ovary were reviewed. patients with recurrent tumors (rec) (n = 19) were compared with patients who remained without disease (ned) (n = 51).

Results:

Significant differences in stage and tumor size were noted between the two groups; however, after logistic regression analysis, only stage remained statistically significant. pathologic evaluation revealed that call-exner bodies occurred more frequently in tumors of the ned patients. cellular atypia and high mitotic rates were more frequent in the rec group; however, after logistic regression analysis, only atypia remained statistically significant. when early (< 10 years) and late recurring tumors (> 10 years) were compared, statistically significant differences were again noted: early recurring tumors had fewer call-exner bodies, higher mitotic rates, and higher degrees of atypia; late recurring tumors were similar to tumors in the ned patients.

Conclusions:

Tumor stage and, to a lesser extent, tumor size are the only clinical parameters of prognostic importance in adult granulosa cell tumors. cellular atypia and, to lesser extents, mitotic rate and the absence of call-exner bodies are the only significant pathologic prognosticators. it is difficult to predict early recurrences and impossible to predict late recurrences using these clinical and pathologic parameters.


πŸ“œ SIMILAR VOLUMES


Differences in prognostic factors betwee
✍ Yoshinori Shimamoto; Kazutoshi Ono; Masayuki Sano; Miwako Matsuzaki; Kenji Suga; πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 435 KB πŸ‘ 1 views

analysis, the patients were divided into two groups: those with the leukemia type ATL and those with the lymphoma type. The prognostic factors have been evaluated separately for each of the types as well.

Prognostic significance of tumor necrosi
✍ Tien-Anh Tran; Bhaskar V. S. Kallakury; Robert A. Ambros; Jeffrey S. Ross πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 345 KB πŸ‘ 2 views

## BACKGROUND. In vitro studies have shown an antiproliferative effect of tumor necrosis factor (TNF) against various nonsmall cell lung carcinoma (NSCLC) cell lines. However, clinical trials of combined interleukin-2 and TNF-␣ in patients with advanced NSCLC have demonstrated both conflicting and

Proportion of S-phase tumor cells measur
✍ A. MaΓ­llo; P. DΓ­az; A. Blanco; A. LΓ³pez; J. Ciudad; J. HernΓ‘ndez; F. Morales; J. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 108 KB

Meningiomas are tumors in arachnoid cells which represent up to one fifth of all intracranial tumors and up to a quarter of spinal neoplasias. Although meningiomas have classically been considered to be benign tumors, it has also been well-established that they show a heterogeneous clinical outcome.